Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Takeda UK Ltd
Takeda House, Mercury Park, Wycombe Lane, Wooburn Green, High Wycombe, Buckinghamshire, HP10 0HH
Telephone: +44 (0)1628 537 900
Fax: +44 (0)1628 526 615
WWW: http://www.Takeda.co.uk
Medical Information Direct Line: +44 (0)1628 537 900
Medical Information e-mail: medinfo@takeda.co.uk
Medical Information Fax: +44 (0)1628 526 617

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 20/01/2012
PIL Actos Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 20/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
Updated on 28/01/2011 and displayed until 20/01/2012
Reasons for adding or updating:
  • Change to date of revision
Updated on 23/12/2010 and displayed until 28/01/2011
Reasons for adding or updating:
  • Change to date of revision
  • PIL Submitted in error
Updated on 28/04/2010 and displayed until 23/12/2010
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 08/04/2009 and displayed until 28/04/2010
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 30/10/2008 and displayed until 08/04/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 20/09/2007 and displayed until 30/10/2008
Reasons for adding or updating:
  • Change to side-effects
Updated on 10/09/2007 and displayed until 20/09/2007
Reasons for adding or updating:
  • Change to side-effects
Updated on 28/02/2007 and displayed until 10/09/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to, or new, use for medicine
  • Change of contra-indications
  • Change to MA holder contact details
Updated on 02/11/2006 and displayed until 28/02/2007
Reasons for adding or updating:
  • Change to side-effects
Updated on 27/05/2005 and displayed until 02/11/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 12/11/2003 and displayed until 27/05/2005
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC
Updated on 05/09/2003 and displayed until 12/11/2003
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC
Updated on 04/09/2003 and displayed until 05/09/2003
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC
Updated on 13/02/2003 and displayed until 04/09/2003
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
  pioglitazone hydrochloride